Active, not recruitingPhase 2NCT05891483

Efficacy and Safety of SHR-1905 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps

Studying Polyrrhinia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Guangdong Hengrui Pharmaceutical Co., Ltd
Intervention
SHR-1905 Injection(drug)
Enrollment
114 target
Eligibility
18-75 years · All sexes
Timeline
20232026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05891483 on ClinicalTrials.gov

Other trials for Polyrrhinia

Additional recruiting or active studies for the same condition.

See all trials for Polyrrhinia

← Back to all trials